Wear the Speed, Live the Convenience: Tappy Technologies Powers the Launch of High Performance Payment Bands in Collaboration with First Abu Dhabi Bank and Mastercard
Transfeero Closes 2025 With Record Growth and a Global Presence in 100 Countries
Plurilock Announces Appointment of New CFO
MiMedia Engages Canaccord Genuity as a Financial Advisor, DS Market Solutions Inc. for Market-Making Services and Announces a Change in Directors
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
The PMDA enters 8th consecutive year of using Certara’s biosimulation software PRINCETON, N.J., June 23,…
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Study highlights the clinical performance of NIS4® technology in diagnosing at-risk NASH in patients with…
FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
HiFi Sequencing will be used on a cohort of rare disease cases with the aim…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
DEINOVE- Adoption of all the ordinary resolutions at the Shareholders’ Meeting of June 21, 2021…
For information Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients To Be Presented…
Saint–Herblain (France), June 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., June 23, 2021 (GLOBE NEWSWIRE) —…
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified…
06_23 PR Image Composite of Alternate Blister Pack Designs (25mg CBD & CBG Infused) NEW…
— Initiation of the ABILITY Study, a first-in-human trial, is expected in the third quarter…
NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a…
NEW ORLEANS and LONDON, June 23, 2021 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
BREXAFEMME® (ibrexafungerp tablets), for oral use A novel oral antifungal approved for the treatment of…
XB2001 Is a Novel Therapy that Interrupts Inflammation to Potentially Block Growth and Spread of…
Subjects receiving the 2.5 mg dose of EB613 showed significant dose-related increases in BMD at…